| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3232 |
| Trial ID | NCT05613348 |
| Disease | B-Cell Acute Lymphoblastic Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAT19T2 |
| Generation | 3rd |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Zhujiang Hospital |
| Other ID(s) | 2022-KY-094 |
| Cohort 1 | |||||||||||
|
|||||||||||